4.3 Article

An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Treatment of facial seborrheic dermatitis with pimecrolimus cream 1%: An open-label clinical study in Korean patients

Byung-Soo Kim et al.

JOURNAL OF KOREAN MEDICAL SCIENCE (2007)

Article Dermatology

Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study

D. Seckin et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2007)

Article Medicine, General & Internal

Pimecrolimus in dermatology: atopic dermatitis and beyond

P Gisondi et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2005)

Article Dermatology

Etiology and management of seborrheic dermatitis

AK Gupta et al.

DERMATOLOGY (2004)

Review Dermatology

Seborrheic dermatitis

AK Gupta et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2004)

Article Dermatology

Is topical metronidazole effective in seborrheic dermatitis?: A double-blind study

R Koca et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2003)

Article Dermatology

Topical tacrolimus and pimecrolimus: Future directions

MR Ling

SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2001)